000 | 01511 a2200385 4500 | ||
---|---|---|---|
005 | 20250513201421.0 | ||
264 | 0 | _c20000201 | |
008 | 200002s 0 0 eng d | ||
022 | _a1525-4135 | ||
024 | 7 |
_a10.1097/00126334-199912010-00004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKatzenstein, D A | |
245 | 0 | 0 |
_aDelayed-type hypersensitivity to recombinant HIV envelope glycoprotein (rgp160) after immunization with homologous antigen. _h[electronic resource] |
260 |
_bJournal of acquired immune deficiency syndromes (1999) _cDec 1999 |
||
300 |
_a341-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAIDS Vaccines _ximmunology |
650 | 0 | 4 |
_aHIV Envelope Protein gp160 _xadverse effects |
650 | 0 | 4 |
_aHIV Infections _ximmunology |
650 | 0 | 4 |
_aHIV-1 _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypersensitivity, Delayed _xetiology |
650 | 0 | 4 | _aLymphocyte Activation |
650 | 0 | 4 | _aSkin Tests |
650 | 0 | 4 | _aVaccination |
650 | 0 | 4 |
_aVaccines, Synthetic _xadverse effects |
700 | 1 | _aKundu, S | |
700 | 1 | _aSpritzler, J | |
700 | 1 | _aSmoller, B R | |
700 | 1 | _aHaszlett, P | |
700 | 1 | _aValentine, F | |
700 | 1 | _aMerigan, T C | |
773 | 0 |
_tJournal of acquired immune deficiency syndromes (1999) _gvol. 22 _gno. 4 _gp. 341-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00126334-199912010-00004 _zAvailable from publisher's website |
999 |
_c10589534 _d10589534 |